Table 1: Initial characteristics of the investigated groups.

HFNon-HFP
(n=78)(n=44)

Age (y)65.1 ± 8.459.6 ± 8.7NS
BMI (kg/m2)27.0 ± 3.527.9 ± 3.4NS
Smokers16 (20%)4 (9%)NS
Hypertension48 (62%)28 (63%)NS
History of MI35 (45%)15 (35%)NS
Systolic BP (mmHg)132.2 ± 12.3127.7 ± 9.00.035
Diastolic BP (mmHg)79.5 ± 5.079.2 ± 4.70NS
LVEDV (cm)5.2 ± 0.35.1 ± 0.8NS
LV EF (%)59 ± 4.559 ± 3.5NS
6-MWT (m)405 ± 62446 ± 630.0007
Blood count:
 RBC4.3 ± 0.74.58 ± 0.60.031
 HGB13.3 ± 2.014 ± 1.9NS
 HCT38.6 ± 5.840.32 ± 5.3NS
 WBC7.9 ± 3.07.42 ± 2.5NS
 PLT192.8 ± 59.9186.64 ± 46.5NS
Electrolytes:
 Na (mmol/L)139.8 ± 14.7141.8 ± 2.8NS
 K (mmol/L)4.5 ± 0.44.5 ± 0.4NS
CRP (mg/L)7.1 ± 8.16.6 ± 9.0NS
TNF (pg/mL)3.3 ± 3.92.6 ± 3.8NS
IL-6 (pg/mL)9.4 ± 5.48.6 ± 6.0NS
NT-proBNP (pg/mL)212.4 ± 101198.3 ± 111NS
eGFR (mL/min/1.73m2)74 ± 13.177.4 ± 11.0NS
Total cholesterol (mmol/L)4.1 ± 0.94.0 ± 0.8NS
LDL-cholesterol (mmol/L)2.2 ± 0.82.2 ± 0.7NS
HDL-cholesterol (mmol/L)1.4 ± 0.31.2 ± 0.30.016
Triglycerides (mmol/L)1.3 ± 0.61.4 ± 0.6NS
Medications:
 Aspirin100%100%NS
 Beta-blockers100%100%NS
 ACE-I91%93%NS
 ARB7 %0 %NS
 Aldosterone antagonists11 %0 %0.007
 Diuretics19 %9 %NS
 Statins99 %98%NS